Recombinant multi-species SLAMF9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLAMF9 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the signaling lymphocytic activation molecule family. The encoded protein is a cell surface molecule that consists of two extracellular immunoglobulin domains, a transmembrane domain and a short cytoplasmic tail that lacks the signal transduction motifs found in other family members. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Apr 2009]
The Alternative Names of target: 2310026I04Rik,CD2 family member 10 (CD2F-10),CD2F-10,CD2F10,CD84 homolog 1 (CD84-H1),CD84-H1,CD84H1,Cd2f10,SF2001,SLAM family member 9,SLAMF9,Slamf9

Target products collectionGo to SLAMF9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1642-Ag-1/ GM-Tg-hg-IP1642-Ag-2 Human SLAMF9 protein Human
GM-Tg-rg-IP1642-Ag-1/ GM-Tg-rg-IP1642-Ag-2 Rat SLAMF9 protein Rat
GM-Tg-mg-IP1642-Ag-1/ GM-Tg-mg-IP1642-Ag-2 Mouse SLAMF9 protein Mouse
GM-Tg-cynog-IP1642-Ag-1/ GM-Tg-cynog-IP1642-Ag-2 Cynomolgus/Rhesus macaque SLAMF9 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1642-Ag-1/ GM-Tg-felg-IP1642-Ag-2 Feline SLAMF9 protein Feline
GM-Tg-cang-IP1642-Ag-1/ GM-Tg-cang-IP1642-Ag-2 Canine SLAMF9 protein Canine
GM-Tg-bovg-IP1642-Ag-1/ GM-Tg-bovg-IP1642-Ag-2 Bovine SLAMF9 protein Bovine
GM-Tg-equg-IP1642-Ag-1/ GM-Tg-equg-IP1642-Ag-2 Equine SLAMF9 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1642-Ag-1/ GM-Tg-hg-IP1642-Ag-2; GM-Tg-rg-IP1642-Ag-1/ GM-Tg-rg-IP1642-Ag-2;
GM-Tg-mg-IP1642-Ag-1/ GM-Tg-mg-IP1642-Ag-2; GM-Tg-cynog-IP1642-Ag-1/ GM-Tg-cynog-IP1642-Ag-2;
GM-Tg-felg-IP1642-Ag-1/ GM-Tg-felg-IP1642-Ag-2; GM-Tg-cang-IP1642-Ag-1/ GM-Tg-cang-IP1642-Ag-2;
GM-Tg-bovg-IP1642-Ag-1/ GM-Tg-bovg-IP1642-Ag-2; GM-Tg-equg-IP1642-Ag-1/ GM-Tg-equg-IP1642-Ag-2
Products Name SLAMF9 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SLAMF9
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SLAMF9 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.